MedTrace Logo

Vektor vMap™ Clinical Validation Study

NCT04559061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2021-04-08

No results posted yet for this study

Summary

This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).

Conditions

  • Cardiac Arrhythmia
  • Atrial Fibrillation
  • Ventricular Arrythmia
  • Premature Ventricular Complexes Multiple
  • Ventricular Tachycardia
  • Ventricular Fibrillation
  • Premature Atrial Complex
  • Atrioventricular Reentrant Tachycardia

Interventions

DEVICE

Cardiac ablation procedure

Retrospective data will be collected from cases where successful ablation was completed.

Sponsors & Collaborators

  • Experien Group

    collaborator UNKNOWN

  • Vektor Medical

    lead INDUSTRY

Principal Investigators

  • Chris Villongco, PhD · Vektor Medical

Eligibility

Min Age
22 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-04-06
Completion
2021-04-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04559061 on ClinicalTrials.gov